Shanghai MicroPort MedBot (Group) Co., Ltd. announce that the SkyWalker Orthopedic Surgical Robot (overseas product name: SkyWalkerTM, SkyWalker'') independently developed by the Group has passed the review of the Brazilian Health Regulatory Agency (ANVISA') and has been approved for marketing in Brazil. This represents another important progress of SkyWalker made by the Group after the successive obtaining of the marketing approval from the National Medical Products Administration (the ``NMPA''), the clearance from the U.S. Food and Drug Administration (the FDA') and the CE Mark last year.